Publications by authors named "Salah El-Tallawy"

Article Synopsis
  • A clinical study was conducted to assess different pain management strategies after cesarean sections (CS) using 300 participants divided into five groups based on their anesthesia methods and analgesic protocols.
  • Results indicated that the group receiving intrathecal morphine (ITM) reported the best pain relief and function, followed closely by the group combining spinal anesthesia with fentanyl and a TAP block (ITF+TAP).
  • The general anesthesia group experienced the worst pain and had the quickest request for additional analgesia, highlighting the effectiveness of multimodal analgesia in enhancing postoperative recovery.
View Article and Find Full Text PDF

Introduction: Endometriosis affects 5% to 10% of reproductive age women and may be associated with severely painful and debilitating symptoms as well as infertility. Endometriosis involves hormonal fluctuations, angiogenesis, neurogenesis, vascular changes and neuroinflammatory processes. The neuroinflammatory component of endometriosis makes it a systemic disorder, similar to other chronic epithelial inflammatory conditions.

View Article and Find Full Text PDF
Article Synopsis
  • Trigeminal neuralgia (TN) is hard to diagnose due to the absence of specific lab tests or biomarkers, and MRI findings are often inconclusive for many patients.* -
  • TN symptoms can be mistaken for other headache disorders like migraines and cluster headaches, leading to treatment complications.* -
  • An accurate diagnosis of TN is critical since it can result in severe pain and decreased quality of life, and there is a possibility that TN is currently being underestimated.*
View Article and Find Full Text PDF
Article Synopsis
  • Trigeminal neuralgia is a rare pain condition often treated with carbamazepine or oxcarbazepine, but these older medications can have significant side effects, prompting interest in newer treatment options like third-generation anticonvulsants and migraine medications.* -
  • There is limited clinical evidence supporting the use of new drugs for trigeminal neuralgia, and currently, no new medications have been specifically approved for the condition in recent years, despite their potential.* -
  • Many patients manage trigeminal neuralgia with a combination of medications, which may allow lower doses of traditional treatments to minimize side effects; however, the risk of drug interactions should be carefully monitored.*
View Article and Find Full Text PDF

Since the COVID-19 pandemic, healthcare systems are facing extraordinary challenges. Our approaches to medicine have changed and created a whole new generation of people who have chronic pain. Various medical services were postponed.

View Article and Find Full Text PDF

First developed in the 1960s in Europe and approved briefly for use in the United States, fenethylline (sold as Captagon, one of its early trade names) is now a prominent drug of abuse in the Eastern Mediterranean Region. The drug was withdrawn from the United States market because of side effects that included hallucinations, visual distortions, and psychosis; it has also been linked to rare cases of myocardial infarction, seizures, and delusions. The chemical synthesis of fenethylline is straightforward and inexpensive.

View Article and Find Full Text PDF

Pain is a significant health issue, and pain assessment is essential for proper diagnosis, follow-up, and effective management of pain. The conventional methods of pain assessment often suffer from subjectivity and variability. The main issue is to understand better how people experience pain.

View Article and Find Full Text PDF

Pain in dementia patients is common, poorly measured, and undertreated. It is important to discuss the challenges in the pain assessment and management to find a possible solution for adequate pain management. The aim of this article is to discuss the challenges in the assessment of pain in geriatric patients with dementia.

View Article and Find Full Text PDF

Objectives: The present study compared the surgical wound catheter (SWC), femoral nerve block (FNB), and adductor canal block (ACB) for postoperative analgesia after knee arthroplasty.

Methods: The study included (180) patients scheduled for unilateral total knee replacement and were randomly allocated into three groups. Patients received postoperative analgesia via continuous infusion of ropivacaine 0.

View Article and Find Full Text PDF

This review is made up of two parts; the first part discussing intellectual disability (ID) in general, while the second part covers the pain associated with intellectual disability and the challenges and practical tips for the management of pain associated with (ID). Intellectual disability is characterized by deficits in general mental abilities, such as reasoning, problem solving, planning, abstract thinking, judgment, academic learning, and learning from experience. ID is a disorder with no definite cause but has multiple risk factors, including genetic, medical, and acquired.

View Article and Find Full Text PDF

An extensive computer search (from January 2020 to January 2023) was conducted including literature from the PubMed, Scopus, MEDLINE, Web of Science, and EMBASE databases. According to preset criteria, a total of 58 articles were included in this review article. Generally, any patient who becomes infected with COVID-19 can develop post-COVID-19 conditions.

View Article and Find Full Text PDF

Musculoskeletal pain is a challenging condition for both patients and physicians. Many adults have experienced one or more episodes of musculoskeletal pain at some time of their lives, regardless of age, gender, or economic status. It affects approximately 47% of the general population.

View Article and Find Full Text PDF

Chronic pain management during the coronavirus disease 2019 (COVID-19) pandemic is a challenging process, especially with growing evidence that COVID-19 infection is associated with myalgias, referred pain, and widespread hyperalgesia. In light of the limited data available for COVID-19-related impact on chronic pain patients, this review explores the changes in the healthcare delivery system due to social distancing and safety precautions to provide the appropriate management of chronic pain patients during the COVID-19 pandemic. Understanding both the general problems facing chronic pain patients as well as specific problems in the COVID-19 era including deconditioning, increased mental health concerns, financial burdens, and potential for medication-induced immune-suppression is vital in the appropriate management of patients.

View Article and Find Full Text PDF

Introduction: Optimal pain management is crucial to the postoperative recovery process. We aimed to evaluate the efficacy and safety of intravenous oxycodone with intravenous fentanyl, morphine, sufentanil, pethidine, and hydromorphone for acute postoperative pain.

Methods: A systematic literature search of PubMed, Cochrane Library, and EMBASE databases was performed for randomized controlled trials published from 2008 through 2017 (inclusive) that evaluated the acute postoperative analgesic efficacy of intravenous oxycodone against fentanyl, morphine, sufentanil, pethidine, and hydromorphone in adult patients (age ≥ 18 years).

View Article and Find Full Text PDF

Objective: To test the hypothesis that identification and blockade of the intercostobrachial nerve (ICBN) can be achieved under ultrasound (US) guidance using a small volume of local anesthetic.

Methods: Twenty-eight adult male volunteers were examined at King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia from November 2012 to September 2013. Intercostobrachial nerve blockade was performed using one ml of 2% lidocaine under US guidance.

View Article and Find Full Text PDF